Login Register Cart 0
Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Probiotics and their Beneficial Health Effects

Author(s): Sumera Zaib*, Aqsa Hayat and Imtiaz Khan*

Volume 24, Issue 1, 2024

Published on: 07 July, 2023

Page: [110 - 125] Pages: 16

DOI: 10.2174/1389557523666230608163823

Price: $65

Abstract

Probiotics are living microorganisms that are present in cultured milk and fermented food. Fermented foods are a rich source for the isolation of probiotics. They are known as good bacteria. They have various beneficial effects on human health including antihypertensive effects, antihypercholesterolemic effects, prevention of bowel disease, and improving the immune system. Microorganisms including bacteria, yeast, and mold are used as probiotics but the major microorganisms that are used as probiotics are bacteria from the genus Lactobacillus, Lactococcus, Streptococcus, and Bifidobacterium. Probiotics are beneficial in the prevention of harmful effects. Recently, the use of probiotics for the treatment of various oral and skin diseases has also gained significant attention. Clinical studies indicate that the usage of probiotics can alter gut microbiota composition and provoke immune modulation in a host. Due to their various health benefits, probiotics are attaining more interest as a substitute for antibiotics or anti-inflammatory drugs leading to the growth of the probiotic market.

« Previous Next »
Graphical Abstract

[1]
Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics. Food including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina1-4 October 20012001 Available from: https://www.fao.org/3/a0512e/a0512e.pdf
[2]
Roberfroid, M.B. Prebiotics and probiotics: Are they functional foods? Am. J. Clin. Nutr., 2000, 71(6)(Suppl. 1), 1682S-1687S.
[http://dx.doi.org/10.1093/ajcn/71.6.1682S] [PMID: 10837317]
[3]
Hill, C.; Guarner, F.; Reid, G.; Gibson, G.R.; Merenstein, D.J.; Pot, B.; Morelli, L.; Canani, R.B.; Flint, H.J.; Salminen, S.; Calder, P.C.; Sanders, M.E. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol., 2014, 11(8), 506-514.
[http://dx.doi.org/10.1038/nrgastro.2014.66] [PMID: 24912386]
[4]
Plaza-Díaz, J.; Ruiz-Ojeda, F.; Gil-Campos, M.; Gil, A. Immune-mediated mechanisms of action of probiotics and synbiotics in treating pediatric intestinal diseases. Nutrients, 2018, 10(1), 42.
[http://dx.doi.org/10.3390/nu10010042] [PMID: 29303974]
[5]
Plaza-Díaz, J.; Robles-Sánchez, C.; Abadía-Molina, F.; Sáez-Lara, M.J.; Vilchez-Padial, L.M.; Gil, Á.; Gómez-Llorente, C.; Fontana, L. Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria. Sci. Data, 2017, 4(1)170186
[http://dx.doi.org/10.1038/sdata.2017.186] [PMID: 29231922]
[6]
Fontana, L.; Bermudez-Brito, M.; Plaza-Diaz, J.; Muñoz-Quezada, S.; Gil, A. Sources, isolation, characterisation and evaluation of probiotics. Br. J. Nutr., 2013, 109(S2)(Suppl. 2), S35-S50.
[http://dx.doi.org/10.1017/S0007114512004011] [PMID: 23360880]
[7]
Gibson, G.R.; Roberfroid, M.B. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr., 1995, 125(6), 1401-1412.
[http://dx.doi.org/10.1093/jn/125.6.1401] [PMID: 7782892]
[8]
Ouwehand, A.C.; Salminen, S.; Isolauri, E. Probiotics: An overview of beneficial effects. Antonie van Leeuwenhoek, 2002, 82(1/4), 279-289.
[http://dx.doi.org/10.1023/A:1020620607611] [PMID: 12369194]
[9]
Islam, S.U. Clinical uses of probiotics. Medicine (Baltimore), 2016, 95(5)e2658
[http://dx.doi.org/10.1097/MD.0000000000002658] [PMID: 26844491]
[10]
Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms. EFSA J., 2016, 14(1), 4369.
[http://dx.doi.org/10.2903/j.efsa.2016.4369]
[11]
Degnan, F.H. The US Food and Drug Administration and probiotics: Regulatory categorization. Clin. Infect. Dis., 2008, 46(s2)(Suppl. 2), S133-S136.
[http://dx.doi.org/10.1086/523324] [PMID: 18181719]
[12]
Hoffmann, D.E. Health claim regulation of probiotics in the USA and the EU: is there a middle way? Benef. Microbes, 2013, 4(1), 109-115.
[http://dx.doi.org/10.3920/BM2012.0033] [PMID: 23257017]
[13]
Didari, T.; Solki, S.; Mozaffari, S.; Nikfar, S.; Abdollahi, M. A systematic review of the safety of probiotics. Expert Opin. Drug Saf., 2014, 13(2), 227-239.
[http://dx.doi.org/10.1517/14740338.2014.872627] [PMID: 24405164]
[14]
Szajewska, H. What are the indications for using probiotics in children? Arch. Dis. Child., 2016, 101(4), 398-403.
[http://dx.doi.org/10.1136/archdischild-2015-308656] [PMID: 26347386]
[15]
Newberry, S.J.; Newberry, S.J.; Maher, A.R.; Wang, Z.; Miles, J.N.; Shanman, R.; Johnsen, B.; Shekelle, P.G. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: A systematic review and meta-analysis. JAMA, 2012, 307(18), 1959-1969.
[http://dx.doi.org/10.1001/jama.2012.3507] [PMID: 22570464]
[16]
Moayyedi, P.; Ford, A.C.; Talley, N.J.; Cremonini, F.; Foxx-Orenstein, A.E.; Brandt, L.J.; Quigley, E.M.M. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut, 2010, 59(3), 325-332.
[http://dx.doi.org/10.1136/gut.2008.167270] [PMID: 19091823]
[17]
Saez-Lara, M.J.; Gomez-Llorente, C.; Plaza-Diaz, J.; Gil, A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: A systematic review of randomized human clinical trials. BioMed Res. Int., 2015, 2015, 1-15.
[http://dx.doi.org/10.1155/2015/505878] [PMID: 25793197]
[18]
Rather, I.A.; Bajpai, V.K.; Kumar, S.; Lim, J.; Paek, W.K.; Park, Y.H. Probiotics and atopic dermatitis: An overview. Front. Microbiol., 2016, 7, 507.
[http://dx.doi.org/10.3389/fmicb.2016.00507] [PMID: 27148196]
[19]
Plaza-Diaz, J.; Ruiz-Ojeda, F.J.; Gil-Campos, M.; Gil, A. Mechanisms of action of probiotics. Adv. Nutr., 2019, 10(Suppl. 1), S49-S66.
[http://dx.doi.org/10.1093/advances/nmy063] [PMID: 30721959]
[20]
Veiga, P.; Suez, J.; Derrien, M.; Elinav, E. Moving from probiotics to precision probiotics. Nat. Microbiol., 2020, 5(7), 878-880.
[http://dx.doi.org/10.1038/s41564-020-0721-1] [PMID: 32393856]
[21]
Mizock, B.A. Probiotics. Dis. Mon., 2015, 61(7), 259-290.
[http://dx.doi.org/10.1016/j.disamonth.2015.03.011] [PMID: 25921792]
[22]
Maldonado-Gómez, M.X.; Martínez, I.; Bottacini, F.; O’Callaghan, A.; Ventura, M.; van Sinderen, D.; Hillmann, B.; Vangay, P.; Knights, D.; Hutkins, R.W.; Walter, J. Stable engraftment of Bifidobacterium longum AH1206 in the human gut depends on individualized features of the resident microbiome. Cell Host Microbe, 2016, 20(4), 515-526.
[http://dx.doi.org/10.1016/j.chom.2016.09.001] [PMID: 27693307]
[23]
Zhang, C.; Derrien, M.; Levenez, F.; Brazeilles, R.; Ballal, S.A.; Kim, J.; Degivry, M.C.; Quéré, G.; Garault, P.; van Hylckama Vlieg, J.E.T.; Garrett, W.S.; Doré, J.; Veiga, P. Ecological robustness of the gut microbiota in response to ingestion of transient food-borne microbes. ISME J., 2016, 10(9), 2235-2245.
[http://dx.doi.org/10.1038/ismej.2016.13] [PMID: 26953599]
[24]
Mack, D.R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. Gastrointest. Liver Physiol., 1999, 276(4), G941-G950.
[http://dx.doi.org/10.1152/ajpgi.1999.276.4.G941] [PMID: 10198338]
[25]
Scarpellini, E.; Cazzato, A.; Lauritano, C.; Gabrielli, M.; Lupascu, A.; Gerardino, L.; Abenavoli, L.; Petruzzellis, C.; Gasbarrini, G.; Gasbarrini, A. Probiotics: Which and when? Dig. Dis., 2008, 26(2), 175-182.
[http://dx.doi.org/10.1159/000116776] [PMID: 18431068]
[26]
Fouhy, F.; Guinane, C.M.; Hussey, S.; Wall, R.; Ryan, C.A.; Dempsey, E.M.; Murphy, B.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C.; Cotter, P.D. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob. Agents Chemother., 2012, 56(11), 5811-5820.
[http://dx.doi.org/10.1128/AAC.00789-12] [PMID: 22948872]
[27]
Dominguez-Bello, M.G.; Blaser, M.J.; Ley, R.E.; Knight, R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology, 2011, 140(6), 1713-1719.
[http://dx.doi.org/10.1053/j.gastro.2011.02.011] [PMID: 21530737]
[28]
Claesson, M.J.; Jeffery, I.B.; Conde, S.; Power, S.E.; O’Connor, E.M.; Cusack, S.; Harris, H.M.B.; Coakley, M.; Lakshminarayanan, B.; O’Sullivan, O.; Fitzgerald, G.F.; Deane, J.; O’Connor, M.; Harnedy, N.; O’Connor, K.; O’Mahony, D.; van Sinderen, D.; Wallace, M.; Brennan, L.; Stanton, C.; Marchesi, J.R.; Fitzgerald, A.P.; Shanahan, F.; Hill, C.; Ross, R.P.; O’Toole, P.W. Gut microbiota composition correlates with diet and health in the elderly. Nature, 2012, 488(7410), 178-184.
[http://dx.doi.org/10.1038/nature11319] [PMID: 22797518]
[29]
De Vuyst, L.; Leroy, F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol., 2011, 149(1), 73-80.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2011.03.003] [PMID: 21450362]
[30]
Pryde, S.E.; Duncan, S.H.; Hold, G.L.; Stewart, C.S.; Flint, H.J. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett., 2002, 217(2), 133-139.
[http://dx.doi.org/10.1111/j.1574-6968.2002.tb11467.x] [PMID: 12480096]
[31]
Macfarlane, G.T.; Macfarlane, S.; Blackett, K.L. Fermentation and the effects of probiotics on host metabolism. Probiotics: Clin; Guide, 2010, pp. 83-94.
[32]
Steinhart, A.H.; Hiruki, T.; Brzezinski, A.; Baker, J.P. Treatment of left-sided ulcerative colitis with butyrate enemas: A controlled trial. Aliment. Pharmacol. Ther., 1996, 10(5), 729-736.
[http://dx.doi.org/10.1046/j.1365-2036.1996.d01-509.x] [PMID: 8899080]
[33]
Senok, A.C.; Ismaeel, A.Y.; Botta, G.A. Probiotics: Facts and myths. Clin. Microbiol. Infect., 2005, 11(12), 958-966.
[http://dx.doi.org/10.1111/j.1469-0691.2005.01228.x] [PMID: 16307549]
[34]
Sharifi-Rad, J.; Rodrigues, C.F. Stojanović-Radić Z.; Dimitrijević M.; Aleksić A.; Neffe-Skocińska, K.; Zielińska, D.; Kołożyn-Krajewska, D.; Salehi, B.; Milton Prabu, S.; Schutz, F.; Docea, A.O.; Martins, N.; Calina, D. Probiotics: Versatile bioactive components in promoting human health. Medicina (Kaunas), 2020, 56(9), 433.
[http://dx.doi.org/10.3390/medicina56090433] [PMID: 32867260]
[35]
Sharifi-Rad, M.; Anil Kumar, N.V.; Zucca, P.; Varoni, E.M.; Dini, L.; Panzarini, E.; Rajkovic, J.; Tsouh Fokou, P.V.; Azzini, E.; Peluso, I.; Prakash Mishra, A.; Nigam, M.; El Rayess, Y.; Beyrouthy, M.E.; Polito, L.; Iriti, M.; Martins, N.; Martorell, M.; Docea, A.O.; Setzer, W.N.; Calina, D.; Cho, W.C.; Sharifi-Rad, J. Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front. Physiol., 2020, 11, 694.
[http://dx.doi.org/10.3389/fphys.2020.00694] [PMID: 32714204]
[36]
Kechagia, M.; Basoulis, D.; Konstantopoulou, S.; Dimitriadi, D.; Gyftopoulou, K.; Skarmoutsou, N.; Fakiri, E.M. Health benefits of probiotics: A review. ISRN Nutr., 2013, 2013, 1-7.
[http://dx.doi.org/10.5402/2013/481651] [PMID: 24959545]
[37]
D’Amelio, P.; Sassi, F. Gut microbiota, immune system, and bone. Calcif. Tissue Int., 2018, 102(4), 415-425.
[http://dx.doi.org/10.1007/s00223-017-0331-y] [PMID: 28965190]
[38]
Gómez-Llorente, C.; Muñoz, S.; Gil, A. Role of Toll-like receptors in the development of immunotolerance mediated by probiotics. Proc. Nutr. Soc., 2010, 69(3), 381-389.
[http://dx.doi.org/10.1017/S0029665110001527] [PMID: 20416121]
[39]
Claes, A.K.; Zhou, J.Y.; Philpott, D.J. NOD-like receptors: Guardians of intestinal mucosal barriers. Physiology (Bethesda), 2015, 30(3), 241-250.
[http://dx.doi.org/10.1152/physiol.00025.2014] [PMID: 25933824]
[40]
Hevia, A.; Delgado, S.; Sánchez, B.; Margolles, A. Molecular players involved in the interaction between beneficial bacteria and the immune system. Front. Microbiol., 2015, 6, 1285.
[http://dx.doi.org/10.3389/fmicb.2015.01285] [PMID: 26635753]
[41]
Yousefi, M.; Movassaghpour, A.A.; Shamsasenjan, K.; Ghalamfarsa, G.; Sadreddini, S.; Jadidi-Niaragh, F.; Hojjat-Farsangi, M. The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia. Future Oncol., 2015, 11(10), 1567-1582.
[http://dx.doi.org/10.2217/fon.14.298] [PMID: 25963433]
[42]
Giorgetti, G.; Brandimarte, G.; Fabiocchi, F.; Ricci, S.; Flamini, P.; Sandri, G.; Trotta, M.C.; Elisei, W.; Penna, A.; Lecca, P.G.; Picchio, M.; Tursi, A. Interactions between innate immunity, microbiota, and probiotics. J. Immunol. Res., 2015, 2015, 1-7.
[http://dx.doi.org/10.1155/2015/501361] [PMID: 26090492]
[43]
Bermudez-Brito, M.; Plaza-Díaz, J.; Muñoz-Quezada, S.; Gómez-Llorente, C.; Gil, A. Probiotic mechanisms of action. Ann. Nutr. Metab., 2012, 61(2), 160-174.
[http://dx.doi.org/10.1159/000342079] [PMID: 23037511]
[44]
Wells, J.M. Immunomodulatory mechanisms of lactobacilli. Microb. Cell Fact., 2011, 10(Suppl. 1), S17.
[http://dx.doi.org/10.1186/1475-2859-10-S1-S17] [PMID: 21995674]
[45]
Vinderola, G.; Matar, C.; Perdigón, G. Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: Involvement of toll-like receptors. Clin. Vaccine Immunol., 2005, 12(9), 1075-1084.
[http://dx.doi.org/10.1128/CDLI.12.9.1075-1084.2005] [PMID: 16148174]
[46]
Ren, C.; Zhang, Q.; de Haan, B.J.; Zhang, H.; Faas, M.M.; de Vos, P. Identification of TLR2/TLR6 signalling lactic acid bacteria for supporting immune regulation. Sci. Rep., 2016, 6(1), 34561.
[http://dx.doi.org/10.1038/srep34561] [PMID: 27708357]
[47]
Shida, K.; Kiyoshima-Shibata, J.; Kaji, R.; Nagaoka, M.; Nanno, M. Peptidoglycan from lactobacilli inhibits interleukin-12 production by macrophages induced by Lactobacillus casei through Toll-like receptor 2-dependent and independent mechanisms. Immunology, 2009, 128(1pt2), e858-e869.
[http://dx.doi.org/10.1111/j.1365-2567.2009.03095.x] [PMID: 19740347]
[48]
Abreu, M.T.; Fukata, M.; Arditi, M. TLR signaling in the gut in health and disease. J. Immunol., 2005, 174(8), 4453-4460.
[http://dx.doi.org/10.4049/jimmunol.174.8.4453] [PMID: 15814663]
[49]
Castillo, N.A.; Perdigón, G.; de Moreno de LeBlanc, A. Oral administration of a probiotic Lactobacillus modulates cytokine production and TLR expression improving the immune response against Salmonella enterica serovar Typhimurium infection in mice. BMC Microbiol., 2011, 11(1), 177-189.
[http://dx.doi.org/10.1186/1471-2180-11-177] [PMID: 21813005]
[50]
Karczewski, J.; Troost, F.J.; Konings, I.; Dekker, J.; Kleerebezem, M.; Brummer, R.J.M.; Wells, J.M. Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am. J. Physiol. Gastrointest. Liver Physiol., 2010, 298(6), G851-G859.
[http://dx.doi.org/10.1152/ajpgi.00327.2009] [PMID: 20224007]
[51]
Compare, D.; Rocco, A.; Coccoli, P.; Angrisani, D.; Sgamato, C.; Iovine, B.; Salvatore, U.; Nardone, G. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: An ex-vivo organ culture model of post-infectious irritable bowel syndrome. BMC Gastroenterol., 2017, 17(1), 53.
[http://dx.doi.org/10.1186/s12876-017-0605-x] [PMID: 28410580]
[52]
Hoarau, C.; Martin, L.; Faugaret, D.; Baron, C.; Dauba, A.; Aubert-Jacquin, C.; Velge-Roussel, F.; Lebranchu, Y. Supernatant from bifidobacterium differentially modulates transduction signaling pathways for biological functions of human dendritic cells. PLoS One, 2008, 3(7)e2753
[http://dx.doi.org/10.1371/journal.pone.0002753] [PMID: 18648505]
[53]
Zeuthen, L.H.; Fink, L.N.; Frøkiaer, H. Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells. Immunology, 2008, 124(4), 489-502.
[http://dx.doi.org/10.1111/j.1365-2567.2007.02800.x] [PMID: 18217947]
[54]
Lee, J.; Mo, J.H.; Katakura, K.; Alkalay, I.; Rucker, A.N.; Liu, Y.T.; Lee, H.K.; Shen, C.; Cojocaru, G.; Shenouda, S.; Kagnoff, M.; Eckmann, L.; Ben-Neriah, Y.; Raz, E. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat. Cell Biol., 2006, 8(12), 1327-1336.
[http://dx.doi.org/10.1038/ncb1500] [PMID: 17128265]
[55]
Plantinga, T.S.; van Maren, W.W.C.; van Bergenhenegouwen, J.; Hameetman, M.; Nierkens, S.; Jacobs, C.; de Jong, D.J.; Joosten, L.A.B.; van’t Land, B.; Garssen, J.; Adema, G.J.; Netea, M.G. Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin. Vaccine Immunol., 2011, 18(4), 621-628.
[http://dx.doi.org/10.1128/CVI.00498-10] [PMID: 21288993]
[56]
Hee Kim, C.; Geun Kim, H.; Yun Kim, J.; Ra Kim, N.; Jun Jung, B.; Hye Jeong, J.; Kyun Chung, D. Probiotic genomic DNA reduces the production of pro-inflammatory cytokine tumor necrosis factor-alpha. FEMS Microbiol. Lett., 2012, 328(1), 13-19.
[http://dx.doi.org/10.1111/j.1574-6968.2011.02470.x] [PMID: 22126103]
[57]
Good, M.; Sodhi, C.P.; Ozolek, J.A.; Buck, R.H.; Goehring, K.C.; Thomas, D.L.; Vikram, A.; Bibby, K.; Morowitz, M.J.; Firek, B.; Lu, P.; Hackam, D.J. Lactobacillus rhamnosus HN001 decreases the severity of necrotizing enterocolitis in neonatal mice and preterm piglets: evidence in mice for a role of TLR9. Am. J. Physiol. Gastrointest. Liver Physiol., 2014, 306(11), G1021-G1032.
[http://dx.doi.org/10.1152/ajpgi.00452.2013] [PMID: 24742987]
[58]
West, C.E.; Jenmalm, M.C.; Prescott, S.L. The gut microbiota and its role in the development of allergic disease: A wider perspective. Clin. Exp. Allergy, 2015, 45(1), 43-53.
[http://dx.doi.org/10.1111/cea.12332] [PMID: 24773202]
[59]
McFarland, L.V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea. Travel Med. Infect. Dis., 2007, 5(2), 97-105.
[http://dx.doi.org/10.1016/j.tmaid.2005.10.003] [PMID: 17298915]
[60]
Lawley, T.D.; Clare, S.; Walker, A.W.; Stares, M.D.; Connor, T.R.; Raisen, C.; Goulding, D.; Rad, R.; Schreiber, F.; Brandt, C.; Deakin, L.J.; Pickard, D.J.; Duncan, S.H.; Flint, H.J.; Clark, T.G.; Parkhill, J.; Dougan, G. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog., 2012, 8(10)e1002995
[http://dx.doi.org/10.1371/journal.ppat.1002995] [PMID: 23133377]
[61]
Doron, S.I.; Hibberd, P.L.; Gorbach, S.L. Probiotics for prevention of antibiotic-associated diarrhea. J. Clin. Gastroenterol., 2008, 42(Suppl. 2), S58-S63.
[http://dx.doi.org/10.1097/MCG.0b013e3181618ab7] [PMID: 18542041]
[62]
Choi, C.H.; Jo, S.Y.; Park, H.J.; Chang, S.K.; Byeon, J.S.; Myung, S.J. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: Effect on quality of life. J. Clin. Gastroenterol., 2011, 45(8), 679-683.
[http://dx.doi.org/10.1097/MCG.0b013e318204593e] [PMID: 21301358]
[63]
Kruis, W. Frič P.; Pokrotnieks, J.; Lukás, M.; Fixa, B.; Kascák, M.; Kamm, M.A.; Weismueller, J.; Beglinger, C.; Stolte, M.; Wolff, C.; Schulze, J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut, 2004, 53(11), 1617-1623.
[http://dx.doi.org/10.1136/gut.2003.037747] [PMID: 15479682]
[64]
Lund, B.; Edlund, C. Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster. Clin. Infect. Dis., 2001, 32(9), 1384-1385.
[http://dx.doi.org/10.1086/319994] [PMID: 11303279]
[65]
Klein, G.; Hallmann, C.; Casas, I.A.; Abad, J.; Louwers, J.; Reuter, G. Exclusion of vanA, vanB and vanC type glycopeptide resistance in strains of Lactobacillus reuteri and Lactobacillus rhamnosus used as probiotics by polymerase chain reaction and hybridization methods. J. Appl. Microbiol., 2000, 89(5), 815-824.
[http://dx.doi.org/10.1046/j.1365-2672.2000.01187.x] [PMID: 11119156]
[66]
Szajewska, H.; Guarino, A.; Hojsak, I.; Indrio, F.; Kolacek, S.; Shamir, R.; Vandenplas, Y.; Weizman, Z. Use of probiotics for management of acute gastroenteritis: A position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr., 2014, 58(4), 531-539.
[http://dx.doi.org/10.1097/MPG.0000000000000320] [PMID: 24614141]
[67]
Marteau, P.R.; Vrese, M.; Cellier, C.J.; Schrezenmeir, J. Protection from gastrointestinal diseases with the use of probiotics. Am. J. Clin. Nutr., 2001, 73(2)(Suppl.), 430s-436s.
[http://dx.doi.org/10.1093/ajcn/73.2.430s] [PMID: 11157353]
[68]
Girardin, M.; Frossard, J.L. The role of probiotics in the treatment of inflammatory bowel diseases. . Rev. Med. Suisse, 2012, 8(352), 1674-1676, 1678..
[PMID: 22988728]
[69]
Dinleyici, E.C.; Kara, A.; Dalgic, N.; Kurugol, Z.; Arica, V.; Metin, O.; Temur, E.; Turel, O.; Guven, S.; Yasa, O.; Bulut, S.; Tanir, G.; Yazar, A.S.; Karbuz, A.; Sancar, M.; Erguven, M.; Akca, G.; Eren, M.; Ozen, M.; Vandenplas, Y. Saccharomyces boulardii CNCM I-745 reduces the duration of diarrhoea, length of emergency care and hospital stay in children with acute diarrhoea. Benef. Microbes, 2015, 6(4), 415-421.
[http://dx.doi.org/10.3920/BM2014.0086] [PMID: 25653151]
[70]
Fitzpatrick, L.R.; Hertzog, K.L.; Quatse, A.L.; Koltun, W.A.; Small, J.S.; Vrana, K. Effects of the probiotic formulation VSL#3 on colitis in weanling rats. J. Pediatr. Gastroenterol. Nutr., 2007, 44(5), 561-570.
[http://dx.doi.org/10.1097/MPG.0b013e31803bda51] [PMID: 17460487]
[71]
Zocco, M.A.; Dal Verme, L.Z.; Cremonini, F.; Piscaglia, A.C.; Nista, E.C.; Candelli, M.; Novi, M.; Rigante, D.; Cazzato, I.A.; Ojetti, V.; Armuzzi, A.; Gasbarrini, G.; Gasbarrini, A. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther., 2006, 23(11), 1567-1574.
[http://dx.doi.org/10.1111/j.1365-2036.2006.02927.x] [PMID: 16696804]
[72]
Marteau, P.; Lémann, M.; Seksik, P.; Laharie, D.; Colombel, J.F.; Bouhnik, Y.; Cadiot, G.; Soulé, J.C.; Bourreille, A.; Metman, E.; Lerebours, E.; Carbonnel, F.; Dupas, J.L.; Veyrac, M.; Coffin, B.; Moreau, J.; Abitbol, V.; Blum-Sperisen, S.; Mary, J.Y. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: A randomised, double blind, placebo controlled GETAID trial. Gut, 2006, 55(6), 842-847.
[http://dx.doi.org/10.1136/gut.2005.076604] [PMID: 16377775]
[73]
Van Gossum, A.; Dewit, O.; Louis, E.; de Hertogh, G.; Baert, F.; Fontaine, F.; DeVos, M.; Enslen, M.; Paintin, M.; Franchimont, D. Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohnʼs disease after ileo-caecal resection. Inflamm. Bowel Dis., 2007, 13(2), 135-142.
[http://dx.doi.org/10.1002/ibd.20063] [PMID: 17206696]
[74]
Cristofori, F.; Indrio, F.; Miniello, V.; De Angelis, M.; Francavilla, R. Probiotics in celiac disease. Nutrients, 2018, 10(12), 1824.
[http://dx.doi.org/10.3390/nu10121824] [PMID: 30477107]
[75]
Crovesy, L.; Gongalves, D.C.; Trigo, E.L. Probiotics in allergy treatment: A literature review. Revista Española de Nutrición Humana y Dietética, 2017, 21(3), 293-299.
[http://dx.doi.org/10.14306/renhyd.21.3.361]
[76]
Stavropoulou, E.; Bezirtzoglou, E. Probiotics in medicine: A long debate. Front. Immunol., 2020, 11, 2192.
[http://dx.doi.org/10.3389/fimmu.2020.02192] [PMID: 33072084]
[77]
Cao, L.; Wang, L.; Yang, L.; Tao, S.; Xia, R.; Fan, W. Long-term effect of early-life supplementation with probiotics on preventing atopic dermatitis: A meta-analysis. J. Dermatolog. Treat., 2015, 26(6), 537-540.
[http://dx.doi.org/10.3109/09546634.2015.1027168] [PMID: 25942569]
[78]
Panduru, M.; Panduru, N.M. Sălăvăstru, C.M.; Tiplica, G.S. Probiotics and primary prevention of atopic dermatitis: A meta‐analysis of randomized controlled studies. J. Eur. Acad. Dermatol. Venereol., 2015, 29(2), 232-242.
[http://dx.doi.org/10.1111/jdv.12496] [PMID: 24698503]
[79]
Kalliomäki, M.; Salminen, S.; Arvilommi, H.; Kero, P.; Koskinen, P.; Isolauri, E. Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet, 2001, 357(9262), 1076-1079.
[http://dx.doi.org/10.1016/S0140-6736(00)04259-8] [PMID: 11297958]
[80]
Wang, I.J.; Wang, J.Y. Children with atopic dermatitis show clinical improvement after Lactobacillus exposure. Clin. Exp. Allergy, 2015, 45(4), 779-787.
[http://dx.doi.org/10.1111/cea.12489] [PMID: 25600169]
[81]
Ishida, Y.; Nakamura, F.; Kanzato, H.; Sawada, D.; Hirata, H.; Nishimura, A.; Kajimoto, O.; Fujiwara, S. Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: A double-blind, placebo-controlled study. J. Dairy Sci., 2005, 88(2), 527-533.
[http://dx.doi.org/10.3168/jds.S0022-0302(05)72714-4] [PMID: 15653517]
[82]
Yonekura, S.; Okamoto, Y.; Okawa, T.; Hisamitsu, M.; Chazono, H.; Kobayashi, K.; Sakurai, D.; Horiguchi, S.; Hanazawa, T. Effects of daily intake of Lactobacillus paracasei strain KW3110 on Japanese cedar pollinosis. Allergy Asthma Proc., 2009, 30(4), 397-405.
[http://dx.doi.org/10.2500/aap.2009.30.3256] [PMID: 19772761]
[83]
Morita, H.; He, F.; Kawase, M.; Kubota, A.; Hiramatsu, M.; Kurisaki, J.I.; Salminen, S. Preliminary human study for possible alteration of serum immunoglobulin E production in perennial allergic rhinitis with fermented milk prepared with Lactobacillus gasseri TMC0356. Microbiol. Immunol., 2006, 50(9), 701-706.
[http://dx.doi.org/10.1111/j.1348-0421.2006.tb03842.x] [PMID: 16985291]
[84]
Xiao, J.Z.; Kondo, S.; Yanagisawa, N.; Takahashi, N.; Odamaki, T.; Iwabuchi, N.; Iwatsuki, K.; Kokubo, S.; Togashi, H.; Enomoto, K.; Enomoto, T. Effect of probiotic Bifidobacterium longum BB536 [corrected] in relieving clinical symptoms and modulating plasma cytokine levels of Japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial. J. Investig. Allergol. Clin. Immunol., 2006, 16(2), 86-93.
[PMID: 16689181]
[85]
Bickert, T.; Trujillo-Vargas, C.M.; Duechs, M.; Wohlleben, G.; Polte, T.; Hansen, G.; Oelschlaeger, T.A.; Erb, K.J. Probiotic Escherichia coli Nissle 1917 suppresses allergen-induced Th2 responses in the airways. Int. Arch. Allergy Immunol., 2009, 149(3), 219-230.
[http://dx.doi.org/10.1159/000199717] [PMID: 19218814]
[86]
Singh, A.; Hacini-Rachinel, F.; Gosoniu, M.L.; Bourdeau, T.; Holvoet, S.; Doucet-Ladeveze, R.; Beaumont, M.; Mercenier, A.; Nutten, S. Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: An exploratory, randomized, placebo-controlled clinical trial. Eur. J. Clin. Nutr., 2013, 67(2), 161-167.
[http://dx.doi.org/10.1038/ejcn.2012.197] [PMID: 23299716]
[87]
Costa, D.J.; Marteau, P.; Amouyal, M.; Poulsen, L.K.; Hamelmann, E.; Cazaubiel, M.; Housez, B.; Leuillet, S.; Stavnsbjerg, M.; Molimard, P.; Courau, S.; Bousquet, J. Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: A double-blind, randomized, placebo-controlled trial (GA2LEN Study). Eur. J. Clin. Nutr., 2014, 68(5), 602-607.
[http://dx.doi.org/10.1038/ejcn.2014.13] [PMID: 24569538]
[88]
Ouwehand, A.C.; Nermes, M.; Collado, M.C.; Rautonen, N.; Salminen, S.; Isolauri, E. Specific probiotics alleviate allergic rhinitis during the birch pollen season. World J. Gastroenterol., 2009, 15(26), 3261-3268.
[http://dx.doi.org/10.3748/wjg.15.3261] [PMID: 19598302]
[89]
Kawase, M.; He, F.; Kubota, A.; Hiramatsu, M.; Saito, H.; Ishii, T.; Yasueda, H.; Akiyama, K. Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical study. Int. J. Food Microbiol., 2009, 128(3), 429-434.
[http://dx.doi.org/10.1016/j.ijfoodmicro.2008.09.017] [PMID: 18977549]
[90]
Felice, G.D.; Barletta, B.; Butteroni, C.; Corinti, S.; Tinghino, R.; Colombo, P.; Boirivant, M. Use of probiotic bacteria for prevention and therapy of allergic diseases: Studies in mouse model of allergic sensitization. J. Clin. Gastroenterol., 2008, 42(Suppl. 3), S130-S132.
[http://dx.doi.org/10.1097/MCG.0b013e318169c463] [PMID: 18806704]
[91]
Meijerink, M.; Wells, J.M.; Taverne, N.; de Zeeuw Brouwer, M.L.; Hilhorst, B.; Venema, K.; van Bilsen, J. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol. Med. Microbiol., 2012, 65(3), 488-496.
[http://dx.doi.org/10.1111/j.1574-695X.2012.00981.x] [PMID: 22540665]
[92]
Peng, G.C.; Hsu, C.H. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr. Allergy Immunol., 2005, 16(5), 433-438.
[http://dx.doi.org/10.1111/j.1399-3038.2005.00284.x] [PMID: 16101937]
[93]
Castellazzi, A.M.; Valsecchi, C.; Caimmi, S.; Licari, A.; Marseglia, A.; Leoni, M.C.; Caimmi, D.; Miraglia del Giudice, M.; Leonardi, S.; La Rosa, M.; Marseglia, G.L. Probiotics and food allergy. Ital. J. Pediatr., 2013, 39(1), 47.
[http://dx.doi.org/10.1186/1824-7288-39-47] [PMID: 23895430]
[94]
Maldonado Galdeano, C.; Cazorla, S.I.; Lemme Dumit, J.M.; Vélez, E.; Perdigón, G. Beneficial effects of probiotic consumption on the immune system. Ann. Nutr. Metab., 2019, 74(2), 115-124.
[http://dx.doi.org/10.1159/000496426] [PMID: 30673668]
[95]
Asher, M.I.; Montefort, S.; Björkstén, B.; Lai, C.K.W.; Strachan, D.P.; Weiland, S.K.; Williams, H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet, 2006, 368(9537), 733-743.
[http://dx.doi.org/10.1016/S0140-6736(06)69283-0] [PMID: 16935684]
[96]
Arrieta, M.C.; Stiemsma, L.T.; Dimitriu, P.A.; Thorson, L.; Russell, S.; Yurist-Doutsch, S.; Kuzeljevic, B.; Gold, M.J.; Britton, H.M.; Lefebvre, D.L.; Subbarao, P. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med., 2015, 7(307)307ra152
[http://dx.doi.org/10.1126/scitranslmed.aab2271] [PMID: 26424567]
[97]
Zhang, B. an, J.; Shimada, T.; Liu, S.; Maeyama, K. Oral administration of Enterococcus faecalis FK-23 suppresses Th17 cell development and attenuates allergic airway responses in mice. Int. J. Mol. Med., 2012, 30(2), 248-254.
[http://dx.doi.org/10.3892/ijmm.2012.1010] [PMID: 22641478]
[98]
Das, R.R.; Naik, S.S.; Singh, M. Probiotics as additives on therapy in allergic airway diseases: A systematic review of benefits and risks. BioMed Res. Int., 2013, 2013, 1-10.
[http://dx.doi.org/10.1155/2013/231979] [PMID: 23956972]
[99]
Abrahamsson, T.R.; Jakobsson, T.; Björkstén, B.; Oldaeus, G.; Jenmalm, M.C. No effect of probiotics on respiratory allergies: A seven-year follow-up of a randomized controlled trial in infancy. Pediatr. Allergy Immunol., 2013, 24(6), 556-561.
[http://dx.doi.org/10.1111/pai.12104] [PMID: 23902407]
[100]
Azad, M.B.; Coneys, J.G.; Kozyrskyj, A.L.; Field, C.J.; Ramsey, C.D.; Becker, A.B.; Friesen, C.; Abou-Setta, A.M.; Zarychanski, R. Probiotic supplementation during pregnancy or infancy for the chemoprevention of asthma and wheeze: Systematic review and metaanalysis. BMJ, 2013, 347(dec04 12), f6471.
[http://dx.doi.org/ 10.1136/bmj.f6471] [PMID: 24304677]
[101]
Martens, K.; Pugin, B.; De Boeck, I.; Spacova, I.; Steelant, B.; Seys, S.F.; Lebeer, S.; Hellings, P.W. Probiotics for the airways: Potential to improve epithelial and immune homeostasis. Allergy, 2018, 73(10), 1954-1963.
[http://dx.doi.org/10.1111/all.13495] [PMID: 29869783]
[102]
Elborn, J.S. Cystic fibrosis. Lancet, 2016, 388(10059), 2519-2531.
[http://dx.doi.org/10.1016/S0140-6736(16)00576-6] [PMID: 27140670]
[103]
Dumas, A.; Bernard, L.; Poquet, Y.; Lugo-Villarino, G.; Neyrolles, O. The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases. Cell. Microbiol., 2018, 20(12)e12966
[http://dx.doi.org/10.1111/cmi.12966] [PMID: 30329198]
[104]
Alexandre, Y.; Le Blay, G.; Boisramé-Gastrin, S.; Le Gall, F.; Héry-Arnaud, G.; Gouriou, S.; Vallet, S.; Le Berre, R. Probiotics: A new way to fight bacterial pulmonary infections? Med. Mal. Infect., 2014, 44(1), 9-17.
[http://dx.doi.org/10.1016/j.medmal.2013.05.001] [PMID: 23820129]
[105]
Kumar, M.; Nagpal, R.; Kumar, R.; Hemalatha, R.; Verma, V.; Kumar, A.; Chakraborty, C.; Singh, B.; Marotta, F.; Jain, S.; Yadav, H. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Exp. Diabetes Res., 2012, 2012, 1-14.
[http://dx.doi.org/10.1155/2012/902917] [PMID: 22611376]
[106]
Smet, I.D.; Boever, P.D.; Verstraete, W. Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity. Br. J. Nutr., 1998, 79(2), 185-194.
[http://dx.doi.org/10.1079/BJN19980030] [PMID: 9536863]
[107]
LeBlanc, J.G.; Chain, F.; Martín, R.; Bermúdez-Humarán, L.G.; Courau, S.; Langella, P. Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb. Cell Fact., 2017, 16(1), 79.
[http://dx.doi.org/10.1186/s12934-017-0691-z] [PMID: 28482838]
[108]
Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2020. CA Cancer J. Clin., 2020, 70(1), 7-30.
[http://dx.doi.org/10.3322/caac.21590] [PMID: 31912902]
[109]
Pasquereau-Kotula, E.; Martins, M.; Aymeric, L.; Dramsi, S. Significance of Streptococcus gallolyticus subsp. gallolyticus association with colorectal cancer. Front. Microbiol., 2018, 9, 614.
[http://dx.doi.org/10.3389/fmicb.2018.00614] [PMID: 29666615]
[110]
Smet, A.; Kupcinskas, J.; Link, A.; Hold, G.L.; Bornschein, J. The role of microbiota in gastrointestinal cancer and cancer treatment: Chance or curse? Cell. Mol. Gastroenterol. Hepatol., 2022, 13(3), 857-874.
[http://dx.doi.org/10.1016/j.jcmgh.2021.08.013] [PMID: 34506954]
[111]
Liong, M.T. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci., 2008, 9(5), 854-863.
[http://dx.doi.org/10.3390/ijms9050854] [PMID: 19325789]
[112]
Rafter, J. The effects of probiotics on colon cancer development. Nutr. Res. Rev., 2004, 17(2), 277-284.
[http://dx.doi.org/10.1079/NRR200484] [PMID: 19079931]
[113]
Lee, J.W.; Shin, J.G.; Kim, E.H.; Kang, H.E.; Yim, I.B.; Kim, J.Y.; Joo, H.G.; Woo, H.J. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J. Vet. Sci., 2004, 5(1), 41-48.
[http://dx.doi.org/10.4142/jvs.2004.5.1.41] [PMID: 15028884]
[114]
Kim, Y.; Lee, D.; Kim, D.; Cho, J.; Yang, J.; Chung, M.; Kim, K.; Ha, N. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res., 2008, 31(4), 468-473.
[http://dx.doi.org/10.1007/s12272-001-1180-y] [PMID: 18449504]
[115]
Orlando, A.; Refolo, M.G.; Messa, C.; Amati, L.; Lavermicocca, P.; Guerra, V.; Russo, F. Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr. Cancer, 2012, 64(7), 1103-1111.
[http://dx.doi.org/10.1080/01635581.2012.717676] [PMID: 23061912]
[116]
Ma, E.L.; Choi, Y.J.; Choi, J.; Pothoulakis, C.; Rhee, S.H.; Im, E. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int. J. Cancer,, 2010, 127(4)
[http://dx.doi.org/10.1002/ijc.25011] [PMID: 19876926]
[117]
Stein, K.; Borowicki, A.; Scharlau, D.; Schettler, A.; Scheu, K.; Obst, U.; Glei, M. Effects of synbiotic fermentation products on primary chemoprevention in human colon cells. J. Nutr. Biochem., 2012, 23(7), 777-784.
[http://dx.doi.org/10.1016/j.jnutbio.2011.03.022] [PMID: 21840698]
[118]
Kim, Y.; Oh, S.; Yun, H.S.; Oh, S.; Kim, S.H. Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells. . Lett. Appl. Microbiol, 2010, 51(2), 123-130.
[http://dx.doi.org/ 10.1111/j.1472-765X.2010.02859.x ] [PMID: 20536712]
[119]
Salminen, S.; Ouwehand, A.C.; Isolauri, E. Clinical applications of probiotic bacteria. Int. Dairy J., 1998, 8(5-6), 563-572.
[http://dx.doi.org/10.1016/S0958-6946(98)00077-6]
[120]
Javanmard, A.; Ashtari, S.; Sabet, B.; Davoodi, S.H.; Rostami-Nejad, M.; Esmaeil Akbari, M.; Niaz, A.; Mortazavian, A.M. Probiotics and their role in gastrointestinal cancers prevention and treatment. An overview. Gastroenterol. Hepatol. Bed Bench, 2018, 11(4), 284-295.
[PMID: 30425806]
[121]
Collins, F.L.; Rios-Arce, N.D.; Schepper, J.D.; Parameswaran, N.; McCabe, L.R. The potential of probiotics as a therapy for osteoporosis. Microbiol. Spectr.,, 2017, 5(4), 5-4.20.
[http://dx.doi.org/ 10.1128/microbiolspec.BAD-0015-2016] [PMID: 28840819]
[122]
Manolagas, S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev., 2010, 31(3), 266-300.
[http://dx.doi.org/10.1210/er.2009-0024] [PMID: 20051526]
[123]
D’Amelio, P.; Grimaldi, A.; Di Bella, S.; Brianza, S.Z.M.; Cristofaro, M.A.; Tamone, C.; Giribaldi, G.; Ulliers, D.; Pescarmona, G.P.; Isaia, G. Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis. Bone, 2008, 43(1), 92-100.
[http://dx.doi.org/10.1016/j.bone.2008.02.017] [PMID: 18407820]
[124]
Painter, S.E.; Kleerekoper, M.; Camacho, P.M. Secondary osteoporosis: A review of the recent evidence. Endocr. Pract., 2006, 12(4), 436-445.
[http://dx.doi.org/10.4158/EP.12.4.436] [PMID: 16901802]
[125]
Ghishan, F.K.; Kiela, P.R. Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases. Am. J. Physiol. Gastrointest. Liver Physiol., 2011, 300(2), G191-G201.
[http://dx.doi.org/10.1152/ajpgi.00496.2010] [PMID: 21088237]
[126]
Gill, R.K.; Saksena, S.; Tyagi, S.; Alrefai, W.A.; Malakooti, J.; Sarwar, Z.; Turner, J.R.; Ramaswamy, K.; Dudeja, P.K. Serotonin inhibits Na+/H+ exchange activity via 5-HT4 receptors and activation of PKCα in human intestinal epithelial cells. Gastroenterology, 2005, 128(4), 962-974.
[http://dx.doi.org/10.1053/j.gastro.2005.02.011] [PMID: 15825078]
[127]
Yadav, V.K.; Ryu, J.H.; Suda, N.; Tanaka, K.F.; Gingrich, J.A.; Schütz, G.; Glorieux, F.H.; Chiang, C.Y.; Zajac, J.D.; Insogna, K.L.; Mann, J.J.; Hen, R.; Ducy, P.; Karsenty, G. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell, 2008, 135(5), 825-837.
[http://dx.doi.org/10.1016/j.cell.2008.09.059] [PMID: 19041748]
[128]
Ritchie, M.L.; Romanuk, T.N. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One, 2012, 7(4)e34938
[http://dx.doi.org/10.1371/journal.pone.0034938] [PMID: 22529959]
[129]
Ghotaslou, R.; Yeganeh-Sefidan, F.; Salahi-Eshlaqi, B.; Ebrahimzadeh-Leylabadlo, H. Etiology of acute bacterial meningitis in Iran: A systematic review. Acta Med. Iran., 2015, 53(8), 454-461.
[PMID: 26545988]
[130]
Ki Cha, B.; Mun Jung, S.; Hwan Choi, C.; Song, I.D.; Woong Lee, H.; Joon Kim, H.; Hyuk, J.; Kyung Chang, S.; Kim, K.; Chung, W.S.; Seo, J.G. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial. J. Clin. Gastroenterol., 2012, 46(3), 220-227.
[http://dx.doi.org/10.1097/MCG.0b013e31823712b1] [PMID: 22157240]
[131]
Patel, R.M.; Myers, L.S.; Kurundkar, A.R.; Maheshwari, A.; Nusrat, A.; Lin, P.W. Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am. J. Pathol., 2012, 180(2), 626-635.
[http://dx.doi.org/10.1016/j.ajpath.2011.10.025] [PMID: 22155109]
[132]
Ebrahimzadeh Leylabadlo, H.; Heravi, F.S.; Soltani, E.; Abbasi, A.; Kafil, H.S.; Parsaei, M.; Sanaie, S.; Ahmadian, Z.; Ghotaslou, R. The role of gut microbiota in the treatment of irritable bowel syndrome. Rev. Med. Microbiol., 2022, 33(1), e89-e104.
[http://dx.doi.org/10.1097/MRM.0000000000000284]
[133]
Lesbros-Pantoflickova, D.; Corthèsy-Theulaz, I.; Blum, A.L. Helicobacter pylori and Probiotics1. J. Nutr., 2007, 137(3)(Suppl. 2), 812S-818S.
[http://dx.doi.org/10.1093/jn/137.3.812S] [PMID: 17311980]
[134]
Mestre, A.; Sathiya Narayanan, R.; Rivas, D.; John, J.; Abdulqader, M.A.; Khanna, T.; Chakinala, R.C.; Gupta, S. Role of probiotics in the management of Helicobacter pylori. Cureus, 2022, 14(6)e26463
[http://dx.doi.org/10.7759/cureus.26463] [PMID: 35919364]
[135]
Wang, Z.; Sun, W.; Sun, X.; Wang, Y.; Zhou, M. Kaempferol ameliorates Cisplatin induced nephrotoxicity by modulating oxidative stress, inflammation and apoptosis via ERK and NF-κB pathways. AMB Express, 2020, 10(1), 58.
[http://dx.doi.org/10.1186/s13568-020-00993-w] [PMID: 32219583]
[136]
Lionetti, E.; Indrio, F.; Pavone, L.; Borrelli, G.; Cavallo, L.; Francavilla, R. Role of probiotics in pediatric patients with Helicobacter pylori infection: A comprehensive review of the literature. Helicobacter, 2010, 15(2), 79-87.
[http://dx.doi.org/10.1111/j.1523-5378.2009.00743.x] [PMID: 20402810]
[137]
Homan, M.; Orel, R. Are probiotics useful in Helicobacter pylori eradication? World J. Gastroenterol., 2015, 21(37), 10644-10653.
[http://dx.doi.org/10.3748/wjg.v21.i37.10644] [PMID: 26457024]
[138]
Batdorj, B.; Trinetta, V.; Dalgalarrondo, M.; Prévost, H.; Dousset, X.; Ivanova, I.; Haertlé, T.; Chobert, J.M. Isolation, taxonomic identification and hydrogen peroxide production by Lactobacillus delbrueckii subsp. lactis T31, isolated from Mongolian yoghurt: Inhibitory activity on food-borne pathogens. J. Appl. Microbiol., 2007, 103(3), 584-593.
[http://dx.doi.org/10.1111/j.1365-2672.2007.03279.x] [PMID: 17714391]
[139]
Xiong, J. Progress in the gut microbiota in exploring shrimp disease pathogenesis and incidence. Appl. Microbiol. Biotechnol., 2018, 102(17), 7343-7350.
[http://dx.doi.org/10.1007/s00253-018-9199-7] [PMID: 29982924]
[140]
Yu, X.; Meng, X.; Xu, M.; Zhang, X.; Zhang, Y.; Ding, G.; Huang, S.; Zhang, A.; Jia, Z. Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function. EBioMedicine, 2018, 36, 266-280.
[http://dx.doi.org/10.1016/j.ebiom.2018.09.031] [PMID: 30268831]
[141]
Çekin, A.H. Şahintürk, Y.; Akbay Harmandar, F.; Uyar, S.; Oguz Yolcular, B.; Çekin, Y. Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: Impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance Turk. J. Gastroenterol., 2017, 28(1), 3-11.
[http://dx.doi.org/10.5152/tjg.2016.0278] [PMID: 28007678]
[142]
Park, Y.W.; Haenlein, G.F. Milk and dairy products in human nutrition: Production, composition and health; John Wiley & Sons, 2013.
[http://dx.doi.org/10.1002/9781118534168]
[143]
Ibrahim, S.A.; Gyawali, R.; Awaisheh, S.S.; Ayivi, R.D.; Silva, R.C.; Subedi, K.; Aljaloud, S.O.; Anusha Siddiqui, S.; Krastanov, A. Fermented foods and probiotics: An approach to lactose intolerance. J. Dairy Res., 2021, 88(3), 357-365.
[http://dx.doi.org/10.1017/S0022029921000625] [PMID: 34425920]
[144]
Ibrahim, S.A.; Alazzeh, A.Y.; Awaisheh, S.S.; Song, D.; Shahbazi, A.; AbuGhazaleh, A.A. Enhancement of α- and β-galactosidase activity in Lactobacillus reuteri by different metal ions. Biol. Trace Elem. Res., 2010, 136(1), 106-116.
[http://dx.doi.org/10.1007/s12011-009-8519-2] [PMID: 19777168]
[145]
Awaisheh, S.S. Development of probiotic soft cheese manufactured using goat’s milk with the addition of thyme. Milchwissenschaft, 2011, 66(1), 51-54.
[146]
Awaisheh, S.S.; Rababah, T.M.; Rahahleh, R.J.; Haddad, M.A. Development of a novel white soft cheese using kefir starter cultures: Microbiological, physicochemical and sensory properties. Milk Sci Int-Milchwissenschaft, 2016, 69(4), 18-22.
[147]
Mishra, V.; Shah, C.; Mokashe, N.; Chavan, R.; Yadav, H.; Prajapati, J. Probiotics as potential antioxidants: A systematic review. J. Agric. Food Chem., 2015, 63(14), 3615-3626.
[http://dx.doi.org/10.1021/jf506326t] [PMID: 25808285]
[148]
Wang, J.; Tang, H.; Zhang, C.; Zhao, Y.; Derrien, M.; Rocher, E.; van-Hylckama Vlieg, J.E.T.; Strissel, K.; Zhao, L.; Obin, M.; Shen, J. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J., 2015, 9(1), 1-15.
[http://dx.doi.org/10.1038/ismej.2014.99] [PMID: 24936764]
[149]
Homayouni-Rad, A.; Soroush, A.R.; Khalili, L.; Norouzi-Panahi, L.; Kasaie, Z.; Ejtahed, H.S. Diabetes management by probiotics: Ccurrent knowledge and future pespective. Int. J. Vitam. Nutr. Res., 2017, 1(1), 1-13.
[http://dx.doi.org/10.1024/0300-9831/a000273] [PMID: 28436760]
[150]
Holzapfel, W.H.; Schillinger, U. Introduction to pre- and probiotics. Food Res. Int., 2002, 35(2-3), 109-116.
[http://dx.doi.org/10.1016/S0963-9969(01)00171-5]
[151]
Homayouni-Rad, A.; Soroush, A.R.; Khalili, L.; Norouzi-Panahi, L.; Kasaie, Z.; Ejtahed, H.S. Diabetes management by probiotics: Current knowledge and future pespective. Int. J. Vitam. Nutr. Res., 2017, 1(1), 1-13.
[http://dx.doi.org/10.1024/0300-9831/a000273] [PMID: 28436760]
[152]
Saez-Lara, M.J.; Gomez-Llorente, C.; Plaza-Diaz, J.; Gil, A. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: Aa systematic review of randomized human clinical trials. BioMed Res. Int., 2015, 2015(6264), 1-15.
[http://dx.doi.org/10.1155/2015/505878] [PMID: 25793197]
[153]
Dawood, M.A.O.; Koshio, S.; Ishikawa, M.; Yokoyama, S.; El Basuini, M.F.; Hossain, M.S.; Nhu, T.H.; Dossou, S.; Moss, A.S. Effects of dietary supplementation of Lactobacillus rhamnosus or/and Lactococcus lactis on the growth, gut microbiota and immune responses of red sea bream, Pagrus major. Fish Shellfish Immunol., 2016, 49, 275-285.
[http://dx.doi.org/10.1016/j.fsi.2015.12.047] [PMID: 26766177]
[154]
Sivan, A.; Corrales, L.; Hubert, N.; Williams, J.B.; Aquino-Michaels, K.; Earley, Z.M.; Benyamin, F.W.; Man Lei, Y.; Jabri, B.; Alegre, M.L.; Chang, E.B.; Gajewski, T.F. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy. Science, 2015, 350(6264), 1084-1089.
[http://dx.doi.org/10.1126/science.aac4255] [PMID: 26541606]
[155]
Lei, K.; Li, Y.L.; Yu, D.Y.; Rajput, I.R.; Li, W.F. Influence of dietary inclusion of Bacillus licheniformis on laying performance, egg quality, antioxidant enzyme activities, and intestinal barrier function of laying hens. Poult. Sci., 2013, 92(9), 2389-2395.
[http://dx.doi.org/10.3382/ps.2012-02686] [PMID: 23960122]
[156]
Yang, H.L.; Xia, H.Q.; Ye, Y.D.; Zou, W.C.; Sun, Y.Z. Probiotic Bacillus pumilus SE5 shapes the intestinal microbiota and mucosal immunity in grouper Epinephelus coioides. Dis. Aquat. Organ., 2014, 111(2), 119-127.
[http://dx.doi.org/10.3354/dao02772] [PMID: 25266899]
[157]
Rajput, I.R.; Li, L.Y.; Xin, X.; Wu, B.B.; Juan, Z.L.; Cui, Z.W.; Yu, D.Y.; Li, W.F. Effect of Saccharomyces boulardii and Bacillus subtilis B10 on intestinal ultrastructure modulation and mucosal immunity development mechanism in broiler chickens. Poult. Sci., 2013, 92(4), 956-965.
[http://dx.doi.org/10.3382/ps.2012-02845] [PMID: 23472019]
[158]
Asemi, Z.; Zare, Z.; Shakeri, H.; Sabihi, S.; Esmaillzadeh, A. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann. Nutr. Metab., 2013, 63(1-2), 1-9.
[http://dx.doi.org/10.1159/000349922] [PMID: 23899653]
[159]
Kullisaar, T.; Zilmer, M.; Mikelsaar, M.; Vihalemm, T.; Annuk, H.; Kairane, C.; Kilk, A. Two antioxidative lactobacilli strains as promising probiotics. Int. J. Food Microbiol., 2002, 72(3), 215-224.
[http://dx.doi.org/10.1016/S0168-1605(01)00674-2] [PMID: 11845820]
[160]
Bao, Y.; Wang, Z.; Zhang, Y.; Zhang, J.; Wang, L.; Dong, X.; Su, F.; Yao, G.; Wang, S.; Zhang, H. Effect of Lactobacillus plantarum P‐8 on lipid metabolism in hyperlipidemic rat model. Eur. J. Lipid Sci. Technol., 2012, 114(11), 1230-1236.
[http://dx.doi.org/10.1002/ejlt.201100393]
[161]
Martarelli, D.; Verdenelli, M.C.; Scuri, S.; Cocchioni, M.; Silvi, S.; Cecchini, C.; Pompei, P. Effect of a probiotic intake on oxidant and antioxidant parameters in plasma of athletes during intense exercise training. Curr. Microbiol., 2011, 62(6), 1689-1696.
[http://dx.doi.org/10.1007/s00284-011-9915-3] [PMID: 21400082]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy